Biogen stops part of an MS trial; Merck reports more Enflonsia data
Biogen stops part of an MS trial; Merck reports more Enflonsia data
Inhalt nicht verfügbar. Bitte die Originalquelle aufrufen.
Biogen stops part of an MS trial; Merck reports more Enflonsia data
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.